OpenVSafe by OpenVAERS
Search V-safe

F4T-26525-30821

3 vaccinations 12 coded responses 40 check-ins 11 free-text entries 5 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
927 / CA
Registered
2021-04-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Moderna
  2. 2021-04-10
    Registered in v-safe
  3. 2021-04-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eye pain — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Soreness around the eye area
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-23
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Injection site mass, Injection site pain, Pain — Feeling: Good
    Free text: On Saturday 4/17, experienced slight pain and a small lump at the injection sight. Also experienced tiredness and slight body aches. It was gone by the next day and continues to be gone as of today.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-30
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-07
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-05-11
    Dose 2 — Moderna
  14. 2021-05-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  15. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-05-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-09
    Survey response — 6 months, dose 2
    MedDRA: Abdominal pain, Back pain, Dysuria, Headache, Pyrexia, Urinary tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: UTI: fever, back ache, headache, intermittent abdominal pain & pain upon urinating.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-09
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2021-11-10
  31. 2022-01-07
    Dose 3 — Pfizer-BioNTech
  32. 2022-01-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Respiratory tract congestion, Unevaluable event — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Congestion · Healthcare visit (other): Scheduled for tomorrow
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-08
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  34. 2022-01-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Congestion
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Fever · Fatigue or tiredness · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Cough & congestion
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-10
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-01-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school
    Free text: Coughing & runny nose
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough — Feeling: Fair · Fatigue or tiredness
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-01-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Ageusia, Anosmia, Cough — Feeling: Fair · Fatigue or tiredness
    Free text: Cough, loss of smell and taste
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-01-14
    Survey response — day 7, dose 3
    MedDRA: Ageusia, Anosmia, Cough, Sinus congestion — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Sinus congestion, cough, loss of taste and smell.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-01-20
  42. 2022-01-20
  43. 2022-01-21
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-01-24
  45. 2022-01-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-02-04
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  47. 2022-02-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  48. 2022-02-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  49. 2022-04-08
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  50. 2022-07-08
    Survey response — 6 months, dose 3
    MedDRA: Office visit, Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: UTI · Healthcare visit (other): In-person office visit
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-07-08
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  52. 2022-07-11
  53. 2023-01-07
    Survey response — 12 months, dose 3
    MedDRA: Blood pressure increased, Cough, Eczema, Influenza — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  54. 2023-01-07
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  55. 2023-01-09
  56. 2023-01-09
  57. 2023-01-09
  58. 2023-01-09
  59. 2023-01-09

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Moderna
22021-05-11Moderna
32022-01-07Pfizer-BioNTech No

Call center

5 call center cases

5 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-10

Systemic reaction (other): Soreness around the eye area

Release 7 — day 14, dose 1

2021-04-23

Symptoms: On Saturday 4/17, experienced slight pain and a small lump at the injection sight. Also experienced tiredness and slight body aches. It was gone by the next day and continues to be gone as of today.

Release 10 — 6 months, dose 2

2021-11-09

Symptoms: UTI: fever, back ache, headache, intermittent abdominal pain & pain upon urinating.

Release 10 — days 1–6 daily, dose 3

2022-01-08

Systemic reaction (other): Congestion
Healthcare visit (other): Scheduled for tomorrow

2022-01-09

Systemic reaction (other): Congestion

2022-01-10

Systemic reaction (other): Cough & congestion

2022-01-11

Systemic reaction (other): Coughing & runny nose

2022-01-12

Systemic reaction (other): Cough

2022-01-13

Systemic reaction (other): Cough, loss of smell and taste

Release 10 — day 7, dose 3

2022-01-14

Systemic reaction (other): Sinus congestion, cough, loss of taste and smell.

Release 12 — 6 months, dose 3

2022-07-08

Symptoms: UTI
Healthcare visit (other): In-person office visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAbdominal pain · · ✓
SDBack pain · · ✓
SDBlood pressure increased · · ✓
SDCough · · ✓
SDDysuria · · ✓
SDEczema · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDInfluenza · · ✓
SDInjection site mass ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPyrexia · · ✓
SDUrinary tract infection · · ✓
SROAgeusia · · ✓
SROAnosmia · · ✓
SROCough · · ✓
SROEye pain ✓ ✓ ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓
SROSinus congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release